Lamotrigine and Valproic Acid Combination in Bipolar Disorder
When treating bipolar disorder, valproic acid should be discontinued before reaching a maintenance dose of lamotrigine due to significant drug interactions that require lamotrigine dose adjustments and increase the risk of serious skin reactions. 1
Drug Interaction Between Lamotrigine and Valproic Acid
The FDA drug label clearly indicates that valproic acid significantly impacts lamotrigine's pharmacokinetics:
- Valproic acid increases lamotrigine's elimination half-life from 26 to 70 hours (a 165% increase) 1
- This interaction necessitates lamotrigine dose reduction when coadministered with valproic acid 1
- Serious skin reactions (including Stevens-Johnson syndrome and toxic epidermal necrolysis) have been reported with concomitant lamotrigine and valproic acid administration 1
Approach to Managing the Combination
If Both Medications Are Currently Being Used:
- Reduce lamotrigine dose according to the lamotrigine package insert guidelines when used with valproic acid
- Monitor closely for skin reactions, particularly during initiation and dose adjustments
- Consider discontinuing valproic acid before reaching maintenance lamotrigine dose to reduce risk of adverse effects
If Initiating Treatment:
- Start with one medication first (preferably lamotrigine for bipolar depression or valproic acid for mania/mixed episodes)
- Add the second medication only if necessary with appropriate dose adjustments
- Follow slower titration schedules for lamotrigine when combined with valproic acid
Efficacy of the Combination
Despite the interaction concerns, some evidence suggests potential benefits of combination therapy:
- A case series found that 67% of patients receiving lamotrigine plus valproic acid showed improvement in depression symptoms after 3 months 2
- The combination was generally well tolerated with 13% discontinuation rate due to adverse events 2
- For maintenance treatment, combining mood stabilizers may provide better mood stability, though systematic comparisons with monotherapy are limited 3
Considerations for Specific Bipolar Presentations
- For bipolar depression: Lamotrigine has proven efficacy in acute bipolar depression 4, making it a preferred option
- For acute mania: Valproic acid is effective 5, while lamotrigine has not demonstrated similar efficacy
- For maintenance therapy: Consider the predominant polarity of episodes:
- Lamotrigine is more effective in preventing depressive relapses
- Valproic acid is more effective in preventing manic relapses 3
Practical Recommendations
If valproic acid is already established:
- Add lamotrigine at a reduced dose (typically 25mg every other day initially)
- Follow a slower titration schedule (typically half the standard rate)
- Consider discontinuing valproic acid once lamotrigine reaches therapeutic levels
If lamotrigine is already established:
- Adding valproic acid will increase lamotrigine levels
- Reduce lamotrigine dose by approximately 50% when adding valproic acid
- Monitor closely for signs of lamotrigine toxicity
For new treatment initiation:
- Choose the primary medication based on predominant symptom polarity
- Consider monotherapy first before attempting combination
Monitoring Recommendations
- Regular clinical assessment for skin reactions, particularly during initiation and dose adjustments
- Monitor serum levels of valproic acid
- Regular laboratory monitoring including complete blood count, liver function, and renal function
- Assess for neurological side effects that may be potentiated by the combination
Common Pitfalls to Avoid
- Failing to reduce lamotrigine dose when used with valproic acid
- Titrating lamotrigine too quickly when combined with valproic acid
- Overlooking early signs of serious skin reactions
- Inadequate monitoring during medication transitions